Janux Therapeutics' innovative cancer treatment shows promise in reducing side effects and improving patient outcomes, but stock risks remain. See more on JANX.
Record numbers of US executives are selling shares in their companies, as corporate insiders from Goldman Sachs to Tesla and even Donald’s Trump’s own media group cash in on the stock market surge ...
Investor's Business Daily on MSN7h
Palantir, The Newest S&P 500 Stock, Is Leaving Nvidia In The DustPalantir Technologies, the newest S&P 500 member, was the index's best performer in 2024 as of Nov. 15. But that didn't ...
Foundry specializes in finding business efficiencies and trends for corporate clients, while Palantir's AIP helps all types ...
Software firm MicroStrategy rose after it purchased $4.6 billion of bitcoin, further extending its lead as the corporation with the largest digital-currency treasury.
The S&P 500 added 0.4% on Monday, Nov. 18, kicking off a trading week that will feature a highly anticipated earnings report ...
Investors are looking ahead to Nvidia earnings to test the health of the AI trade, as optimism for rate cuts fades.
Live Updates Stocks on the Move Today 9:49 am Here are some notable stocks on the move today: Super Micro Computer: The ...
A Palantir Technologies Inc board member has deleted his X account after posting last week that the company’s plan to move ...
After a dramatic bull run in recent weeks, Palantir Technologies (NYSE: PLTR) stock was finally giving up gains, as investors ...
Palantir is experiencing sharp declines, erasing the 11% growth recorded at the close of the November 15 session.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback